Scarica l'app Stockscreener
127.69
0.40%
-0.775
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Incyte Corp Borsa (INCY) Ultime notizie
INCY Reiterated by HC Wainwright & Co. -- Price Target Maintained at $150 - GuruFocus
H.C. Wainwright reiterates Incyte stock rating on cancer trial data - Investing.com
Incyte (NASDAQ:INCY) Receives Buy Rating from HC Wainwright - MarketBeat
Incyte (NASDAQ:INCY) Earns Buy Rating from Analysts at Canaccord Genuity Group - MarketBeat
H.C. Wainwright reiterates Incyte stock rating on cancer trial data By Investing.com - Investing.com UK
Canaccord Genuity Initiates Incyte at Buy With $152 Price Target - marketscreener.com
DCF Advisers LLC Takes Position in Incyte Corporation $INCY - MarketBeat
BlackRock Inc. Takes $2.04 Billion Position in Incyte Corporation $INCY - MarketBeat
Incyte Corporation: Target Price Consensus and Analysts Recommendations | ICY | US45337C1027 - marketscreener.com
US FDA approves Regeneron's rare bone disorder drug - marketscreener.com
INCY Looks 19.9% Overvalued on GF Value™ as Insider Selling Pers - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
Incyte (INCY) Financial Update: Profit Per Share Surpasses Its Benchmark in the Latest Reading - Vinanet
Incyte Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
Incyte Corp. stock outperforms competitors on strong trading day - MarketWatch
INCY Maintained by Piper Sandler -- Price Target Raised to $130 - GuruFocus
Global Vitiligo Foundation Applauds Incyte’s "Moments of Clarity" Campaign for Elevating Patient Voices and Advancing Vitiligo Awareness - Yahoo Finance
Incyte stock holds at the $120 mark as strong quarterly earnings support valuation - AD HOC NEWS
Incyte (NASDAQ:INCY) Combines High Growth Momentum with a Breakout Setup - ChartMill
State of Wyoming Acquires New Holdings in Incyte Corporation $INCY - MarketBeat
LTS:0J9P EV-to-OCF: 10.03 — 48% Below Median - GuruFocus
55,370 Shares in Incyte Corporation $INCY Bought by Summit Global Investments - MarketBeat
Baird Chautauqua Global Growth Fund's Incyte Corp(INCY) Holding History - GuruFocus
Incyte Corp's Pablo J. Cagnoni Sells 10,803 Shares Under Rule 10b5-1 Plan in August 2026 - Kalkine Media
Incyte Corp (INCY) R&D chief sells 10,803 shares under Rule 10b5-1 plan - Stock Titan
Incyte Corporation (INCY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Incyte Corporation (INCY) has the Bigger Revenue Base, but Could Halozyme Therapeutics, Inc. (HALO) have the Better Economics? - Yahoo Finance
Incyte stock gains support as Q2 2026 sales surge and guidance rises - AD HOC NEWS
Bernstein Adjusts Price Target on Incyte to $104 From $99, Keeps Market Perform Rating - marketscreener.com
Incyte Sales Growth Drives Share Price Gains - FXEmpire
Insight Wealth Strategies LLC Acquires New Position in Incyte Corporation $INCY - MarketBeat
Q4 2025 Incyte Corp Earnings Call Transcript - GuruFocus
Incyte Corp (HAM:ICY) Stock Price, Trades & News - GuruFocus
Incyte Corporation (NASDAQ:INCY): What Could Drive Shares Next? - Kalkine Media
Incyte (INCY) Short Interest & Short Float | Updated Aug 2026 $INCY - MarketBeat
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Bank of America Corp DE Sells 87,913 Shares of Incyte Corporation $INCY - MarketBeat
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Finviz
Incyte Corp (INCY) R&D head sells 10,640 shares in plan trade - Stock Titan
Incyte Corp (INCY) EVP sells 2,207 shares after option exercise - Stock Titan
Incyte Corp (ICY.HA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Incyte Corp. stock outperforms competitors despite losses on the day - MarketWatch
Incyte (NASDAQ:INCY) EVP Sells $5,005,254.54 in Stock - MarketBeat
Incyte Corp (INCY) R&D head sells 15,888 shares, retains 215,444 - Stock Titan
Incyte Corp (INCY) EVP sells 47,954 shares after exercising options - Stock Titan
Quantinno Capital Management LP Raises Position in Incyte Corporation $INCY - MarketBeat
The Manufacturers Life Insurance Company Sells 30,324 Shares of Incyte Corporation $INCY - MarketBeat
Amundi Purchases 229,783 Shares of Incyte Corporation $INCY - MarketBeat
Incyte (INCY) Won EU Approval For Opzelura, Has The Market Already Priced It In? - Yahoo Finance
Incyte Corp. stock underperforms Friday when compared to competitors - MarketWatch
Incyte Corporation (INCY) Stock Forecasts - Yahoo Finance
Bull Harbor Capital LLC Buys New Shares in Incyte Corporation $INCY - MarketBeat
Incyte Earnings: Opzelura Settlement and Latarcibart Improve Outlook Ahead of Jakafi Patent Loss - Morningstar
No-Moat Incyte Faces Jakafi Patent Cliff as Focus Remains on Opzelura and Expanding Portfolio - Morningstar
Incyte Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Incyte Shares Retreat After Best Day In A Year Despite Opzelura EU Nod - Stocktwits
Incyte lifts annual revenue forecast after settlement with CMS - pharma.economictimes.indiatimes.com
Incyte Corporation (INCY) Q2 2026 Earnings Call Transcript - AlphaStreet
1.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):